Cited by 199Restless Legs Syndrome ResearchIron Metabolism and DisordersNeurological diseases and metabolism

Decreased transferrin receptor expression by Neuromelanin cells in restless legs syndrome

Connor, J. R., Wang, X. S., Patton, S. M., Menzies, S. L., Troncoso, J. C., Earley, C. J., Allen, R. P.·2004·Neurology

Abstract

BACKGROUND: Restless legs syndrome (RLS) is a sensory-movement disorder affecting 5 to 10% of the population. Its etiology is unknown, but MRI analyses and immunohistochemical studies on autopsy tissue suggest the substantia nigra (SN) of patients with RLS has subnormal amounts of iron. METHODS: Neuromelanin cells from the SN of four RLS and four control brains were isolated by laser capture microdissection, and a profile of iron-management protein expression was obtained by immunoblot analysis. Binding assays for iron regulatory protein activity were performed on cell homogenates. RESULTS: Ferritin, divalent metal transporter 1, ferroportin, and transferrin receptor (TfR) were decreased in RLS neuromelanin cells compared with control. Transferrin was increased in RLS neuromelanin cells. This protein profile in RLS neuromelanin cells is consistent with iron deficiency with the exception that TfR expression was decreased rather than increased. The concentration and activity of the iron regulatory proteins (IRP1 and IRP2) were analyzed to determine whether there was a functional deficit in the post-transcriptional regulatory mechanism for TfR expression. Total IRP activity, IRP1 activity, and IRP1 protein levels were decreased in RLS, but total IRP2 protein levels were not decreased in RLS. CONCLUSION: Restless legs syndrome may result from a defect in iron regulatory protein 1 in neuromelanin cells that promotes destabilization of the transferrin receptor mRNA, leading to cellular iron deficiency.

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000123251.60485.ac

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Iron misregulation is implicated in the pathology of restless leg syndrome, so that concentrations of TFR, IRP1, DMT1, ferroportin, and heavy-chain ferritin are decreased in dopaminergic neurons of the substantia nigra.

    “Iron misregulation is implicated in the pathology of restless leg syndrome, so that concentrations of TFR, IRP1, DMT1, ferroportin, and heavy-chain ferritin are decreased in dopaminergic neurons of the substantia nigra.198–200”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Connor, J. R., Wang, X. S., Patton, S. M., Menzies, S. L., Troncoso, J. C., Earley, C. J., & Allen, R. P.
Affiliations
Pennsylvania State University (US)
Venue
Neurology
Published
2004-05-11
Volume
62
Issue
9
Pages
1563-1567
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2060362040
Cited by
199
References
36
Citations by year
2026: 4 · 2025: 3 · 2024: 5 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 9 · 2017: 9 · 2016: 4 · 2015: 12 · 2014: 10 · 2013: 9 · 2012: 9
FWCI
9.58
Type
journal article
Language
en
Open access
closed
Locations
  • Neurology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Restless Legs Syndrome Foundation
  • National Institute on Aging (P50AG005146, AG 05146)
  • National Institute of Neurological Disorders and Stroke (R01NS042857, P50NS38377, P50NS038377, NS042857)
Topics
  • Health Sciences › Medicine › Epidemiology › Restless Legs Syndrome Research
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
restless legs syndrome, substantia nigra, transferrin receptor, iron regulatory protein 1, IRP2, iron deficiency, iron metabolism, ferritin, DMT1, ferroportin, transferrin, post-transcriptional regulation, mRNA stability
MeSH terms
Aged, Aged, 80 and over, Female, Humans, Iron, Male, Melanins, Middle Aged, Nerve Tissue Proteins, Neurons, Receptors, Transferrin, Restless Legs Syndrome, RNA, Messenger, Substantia Nigra, Transferrin, Gene Expression, In Situ Hybridization, Anemia, Iron-Deficiency, Iron-Regulatory Proteins, Microdissection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review